A transcriptional deficit of NF‐κB (nuclear factor kappa‐light‐chain‐enhancer of activated B cells) was substantiated by the downregulation of cyclin D1 and of the anti‐apoptotic Bcl2, in line with reduction in tumour cell proliferation and induction of apoptosis, respectively. The gene discussed is BCL2; the disease is neoplasm.